Skip to content
info@acplgroupindia.co.in +91-9266665201 Mon – Sat: 10:00 AM – 6:00 PM
Accredited Consultant
  • Home
  • About
  • Services
    • Regulatory Services

      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology
    • Specialized Services

      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials
    • More Services

      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • New Letter
    • Volume 22
    • Volume 23
    • Volume 24
    • Volume 25
    • Volume 26
    • Volume 27
    • Volume 28
    • Volume 29
  • Blog
  • Contact
Get Started
Accredited Consultant
  • Home
  • About
  • Services
    • Regulatory Services
      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology
    • Specialized Services
      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials
    • More Services
      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • New Letter
    • Volume 22
    • Volume 23
    • Volume 24
    • Volume 25
    • Volume 26
    • Volume 27
    • Volume 28
    • Volume 29
  • Blog
  • Contact
Call Us: +91-9266665201 info@acplgroupindia.co.in
  1. Home
  2. ACPL

ACPL

Aug 14, 2026

CPCB’s New “Lost Credentials” Facility: A Simple Guide for EPR Portal Users

CPCB just made life easier for anyone managing EPR accounts with their new “Lost Credentials” feature. If you’re stuck because…

Read More
Aug 12, 2026

CDSCO Clarifies Regulatory Pathway for Globally Unapproved New Drugs After Phase III Global Clinical Trials

CDSCO Issues Guidance for Importing and Marketing Globally Unapproved New Drugs After Phase III Trials On August 10, 2026, the…

Read More
Aug 10, 2026

BIS Certification: Important Reasons Why Your BIS Application Gets Rejected

Why Your BIS Certification Application Gets Rejected—and What You Can Do About It Getting BIS Certification isn’t just another box…

Read More
Aug 6, 2026

CDSCO Guidance on Common Submission Format for Drug Imports in India: What Pharma Companies Really Need to Know

India’s Central Drugs Standard Control Organization (CDSCO) just rolled out a new Guidance Document for importing and registering drugs—both bulk…

Read More
Aug 1, 2026

Import of Medical Devices into India: CDSCO Import Licence Process

Importing medical devices into India isn’t simple—it’s tightly regulated by the Central Drugs Standard Control Organization, or CDSCO. The Central…

Read More
Aug 1, 2026

Bringing Medical Devices into India: Your Practical Guide to CDSCO Rules

India’s medical device market is booming. Demand keeps rising for new diagnostic and treatment tools, and global manufacturers have noticed—India’s…

Read More
Aug 1, 2026

DSIR Recognition and Approval Services in India: A Practical Guide for R&D Organizations

Innovation keeps industries moving forward, and organizations that put time and money into research and development are right at the…

Read More
Jul 30, 2026

PESO (Petroleum and Explosives Safety Organisation) Registration & Licensing Services in India

PESO, or the Petroleum and Explosives Safety Organisation, stands as India’s central authority for keeping hazardous substances in check. They’re…

Read More
Jul 25, 2026

Navigating the Latest CDSCO Circular: What It Means for India’s Cosmetics Sector

Regulatory compliance has always been the backbone of a trustworthy supply chain, but a recent directive from the Central Drugs…

Read More
Jul 23, 2026

CDSCO Prohibits 16 Fixed Dose Combinations (FDCs): Key Regulatory Update for the Pharmaceutical Industry

CDSCO Bans 16 Fixed Dose Combinations: What Pharma Companies Need to Know Effective June 11, 2026, the Central Drugs Standard…

Read More
1 2 3 4 Next →
Accredited Consultant

India's trusted pharma regulatory affairs consultancy. Over 25 years helping businesses navigate CDSCO, FSSAI, BIS, and all major Indian regulatory frameworks.

Quick Links

  • About ACPL
  • Our Services
  • India Entry Strategy
  • Insights & Blog
  • Contact Us
  • Careers

Key Services

  • CDSCO Registration
  • FSSAI Licensing
  • BIS Certification
  • Pharmacovigilance
  • Clinical Trials
  • EPR Registration

Contact Us

  • B-3, Sector-6, Noida – 201301, Uttar Pradesh, India
  • +91-9266665201
    +91-9310040434
  • info@acplgroupindia.co.in
  • Mon – Sat: 10:00 AM – 6:00 PM

© 2026 Accredited Consultants Private Limited. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
Scroll to Top